EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[Gastric cancer 844. ESD for a metachronous cancer after ESD]

Previous | Next

001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000


Metachronous cancer develops in 1-2%/year after ESD for EGC. Six years after ESD for EGC, a metachronous cancer was found in the lesser curvature aspect of the high body. ESD was done again.

[1st ESD (left)]
ESD: Early gastric carcinoma
1. Location : proximal antrum, greater curvature
2. Gross type : EGC type IIb+IIc
3. Histologic type : tubular adenocarcinoma, moderately differentiated
4. Histologic type by Lauren : intestinal
5. Size of carcinoma : (1) longest diameter, 14 mm (2) vertical diameter, 13 mm
6. Depth of invasion : invades mucosa (lamina propria) (pT1a)
7. Resection margin : free from carcinoma(N), safety margin : distal 11 mm, proximal 12 mm, anterior 18 mm, posterior 12 mm
8. Lymphatic invasion : not identified(N)
9. Venous invasion : not identified(N)
10. Perineural invasion : not identified(N)
11. Microscopic ulcer : absent
12. Histologic heterogeneity: absent

[2nd ESD (right)]
ESD: Early gastric carcinoma
1. Location : high body, lesser curvature
2. Gross type : EGC type IIa+IIc
3. Histologic type : tubular adenocarcinoma, well differentiated
4. Histologic type by Lauren : intestinal
5. Size of carcinoma : (1) longest diameter, 18 mm (2) vertical diameter, 14 mm
6. Depth of invasion : invades mucosa (lamina propria) (pT1a)
7. Resection margin : free from carcinoma(N) safety margin : distal 7 mm, proximal 6 mm, anterior 12 mm, posterior 10 mm, deep 200 §­
8. Lymphatic invasion : not identified(N)
9. Venous invasion : not identified(N)
10. Perineural invasion : not identified(N)
11. Microscopic ulcer : absent
12. Histologic heterogeneity: absent

After ESD for EGC, I usually recommend to do the follow-up examination (EGD and CT) at local secondary hospitals. In this case, the metachronous cancer was found at a local secondary hospital. Thank you very much for the detailed examination.

ÀÇ·áÀü´Þü°èÀÇ À¯Áö´Â ¸Å¿ì Áß¿äÇÑ À̽´ÀÔ´Ï´Ù. ÁßÁõ ±Þ¼º±â º´¿ø¿¡¼­´Â ±ÞÇÑ Ä¡·á¸¦ ÇÏ°í follow upÀº Áý±Ùó 1-2Â÷ ÀÇ·á±â°ü¿¡¼­ ½ÃÇàÇÏ´Â °ÍÀÌ ¿ì¸®³ª¶óÀÇ ÀüüÀûÀÎ ÀÇ·á½Ã½ºÅÛ È¿À²È­¸¦ À§ÇÏ¿© ²À ÇÊ¿äÇÑ ÀÏÀÔ´Ï´Ù. ESD ÈÄ È¯ÀÚ¿¡°Ô ³»½Ã°æ°ú CT°¡ °¡´ÉÇÑ Áý±Ùó 2Â÷ ÀÇ·á±â°üÀ¸·Î µÇÀÇ·Ú °¡½Ç °ÍÀ» ±ÇÇÏ°í ÀÖÀ¸³ª ½ÇÁ¦·Î µÇÀÇ·Ú µÇ´Â ȯÀÚ´Â Àý¹ÝÀÇ Àý¹Ý Á¤µµ ¹Û¿¡ µÇÁö ¾Ê½À´Ï´Ù. ¾ÈŸ±î¿î Çö½ÇÀÔ´Ï´Ù.

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng. (2020-3-23)